Scientists at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and the Spanish Cardiovascular Research Network (CIBERCV), led by Dr. Vicente Andrés, have generated the HGPSrev ...

Last week, families of children and young adults with Progeria welcomed the news that we are one step closer to the first approved treatment for this ultra-rare, devastating condition that causes ...

PEABODY, Mass. & COLUMBUS, Ohio, March 03, 2026--(BUSINESS WIRE)--The Progeria Research Foundation ("PRF"), a nonprofit research organization dedicated to developing treatments and the cure for ...

Progeria, also known as ‘Hutchinson–Gilford progeria syndrome’ or ‘Hutchinson–Gilford syndrome,’ literally means ‘prematurely old’. It was first described as early as 1886 and is defined by the ...

Biomarker has future applications in new drug candidate identification and could be used in broader cardiovascular and aging-related research. PEABODY, MA / ACCESSWIRE / March 15, 2023 / A newly ...

Hutchinson-Gilford syndrome (HGPS, also known as progeria) is a very rare genetic disease that affects fewer than 400 people globally, and for which there is no effective treatment. HGPS is ...

A drug first developed for cancer has shown promise as a treatment for progeria, a rare and fatal rapid-aging disease in children, and it may have implications in treating cardiovascular problems ...

PROGERIA is a rare medical condition that affects children and is often referred to as Benjamin Button disease. The condition is extremely rare with fewer than 1,000 cases reported per year.

Biologists tend not to discuss experimental results on a handful of cells and a single solitary mouse — too preliminary, too sketchy. David Liu of the Broad Institute therefore had no plans to present ...

Children with progeria appear quite normal at birth. The earliest signs of progeria are scleroderma -like symptoms which manifest as changes on the skin. Within a year to two of birth, other physical ...